Filing Details

Accession Number:
0001209191-19-049388
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-09-12 20:01:12
Reporting Period:
2019-09-10
Accepted Time:
2019-09-12 20:01:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
353569 Quidel Corp QDEL In Vitro & In Vivo Diagnostic Substances (2835) 942573850
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1631320 Jr. Donald Michael Abney 12544 High Bluff Drive, Suite 200
San Diego CA 92130
Svp - Distribution No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-09-10 8,798 $15.40 14,226 No 4 M Direct
Common Stock Disposition 2019-09-10 8,798 $65.00 5,790 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Options Disposition 2019-09-10 8,798 $0.00 8,798 $15.40
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
8,798 2026-02-10 No 4 M Direct
Footnotes
  1. The amount of securities beneficially owned following this transaction include an additional 362 shares due to the Reporting Person's purchase of shares pursuant to the Issuer's Employee Stock Purchase Plan.
  2. 17,596 shares vested on 2/10/2018; 8,798 shares vested on 2/10/2019; and 8,798 shares will vest on 2/10/2020.